Unknown

Dataset Information

Combined cellular and biochemical profiling of Bruton’s tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers


ABSTRACT:

SUBMITTER: Kluitmans D 

PROVIDER: S-EPMC12586182 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature